Market Overview

The Glaucoma market is predicted to develop at a compound annual growth rate (CAGR) of 6.35% from 2024 to 2033, when it is projected to reach USD 13.54 billion, based on an average growth pattern. The market is estimated to reach a value of USD 7.32 billion in 2024.

SOURCE: We Market Research

The glaucoma category of eye diseases is characterized by elevated intraocular pressure, which can result in optic nerve damage and blindness. First, the elevated pressure—which is often brought on by fluid accumulation in the eye—affects peripheral vision. Loss of center vision may also happen as it becomes worse. One of the main causes of irreversible blindness is glaucoma, which often has no symptoms in the early stages. Regular ocular examinations are crucial for early detection and treatment. Treatment options include laser therapy, eye medications, and surgery to maintain eyesight and control intraocular pressure. Early management is essential to reduce the long-term impact on visual health.

The Glaucoma market is driven by several important reasons, including the increased global prevalence of glaucoma, an aging population, and developments in diagnostic technology. The market is growing as a result of rising initiatives for routine eye exams and growing awareness of the value of early identification and treatment. Furthermore, novel therapeutic strategies and pharmaceutical advancements support the market's growth. The glaucoma market is also being driven forward by the increased demand for minimally invasive surgical techniques as well as by a rise in research and development activities. In general, the market for glaucoma is kept growing by a mix of population trends, technology advancements, and an emphasis on preventive healthcare.

Market Scope

Glaucoma Industry: Dynamics & Restrains

Market Drivers

Rising Awareness and Screening Programs - The glaucoma market is being driven mostly by increased public awareness and more comprehensive screening programs. As glaucoma becomes more widely known, people become more proactive in seeking out routine eye exams, which encourages early detection and intervention. The increased number of patients receiving diagnoses due to government programs and healthcare organizations' screening campaigns is driving the demand for glaucoma diagnosis methods and therapies. By improving patient outcomes through timely intervention and promoting market expansion through the development of an informed and engaged healthcare consumer base, this increased knowledge promotes the global fight against glaucoma-related visual loss.

Advancements in Diagnostic Technologies - Technological developments in diagnosis have a major role in driving the glaucoma industry. Frequent advancements in tonometry, imaging technology, and other diagnostic instruments facilitate prompt and enhanced identification of glaucoma. Accurate and prompt diagnosis enable medical practitioners to carry out focused treatment regimens, enhancing patient results. Modern technologies improve the effectiveness of managing glaucoma, which raises demand for these sophisticated diagnostic instruments. As a result, the market for glaucoma enjoys a rising market share that is fueled by the incorporation of cutting-edge technologies that improve diagnostic accuracy, expedite patient treatment, and advance efforts to treat this ailment that threatens vision.

Market restrains

Invasive Nature of Surgical Interventions - The glaucoma market is severely constrained by the invasive nature of surgical procedures. Although glaucoma can be effectively managed with surgical treatments, many are reluctant to have such interventions due to the inherent invasiveness and related risks. Preferring less invasive options is partly due to worries about possible risks, recuperation time, and lifestyle disruptions. The overall market potential is limited by this hesitation, which affects the acceptance rates of surgical procedures. Furthermore, the idea that surgery is a last resort may cause a delay in prompt intervention, which could have an impact on patient outcomes and obstruct the wider acceptance of surgical choices in the context of glaucoma treatment.

We Market Research: Glaucoma Dashboard

Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.

Glaucoma Segmentation

Market- By Disease Type Analysis

By Disease Type, the Glaucoma Market is Categories into Angle Closure Glaucoma, Open Angle Glaucoma, Other. Open Angle Glaucoma segment accounts for the largest share of around 64% in 2022.

Open-angle glaucoma, a prevalent form of glaucoma, is primarily driven by elevated intraocular pressure (IOP) due to impaired drainage of aqueous humor through the trabecular meshwork. Risk factors include age, family history, and certain medical conditions. As the aging population grows, the prevalence of open-angle glaucoma is expected to rise, emphasizing the importance of early detection and effective management strategies in the glaucoma market.

The following segments are part of an in-depth analysis of the global Glaucoma Market:

Glaucoma Industry: Regional Analysis

North America Market Forecast

North America dominate the Glaucoma Market with the highest revenue generating market with share of more than 45%. The prevalence of glaucoma in North America, particularly in the senior population, has been a significant contributing cause. Technological advancements in treatment and diagnostic options, along with a strong healthcare infrastructure, support market expansion.

Europe Market Statistics

Europe is the second-largest market for Glaucoma. Europe has a growing aging population, which increases the incidence of glaucoma. Additionally, research and development activities in the region, as well as government initiatives, contribute to market expansion.

Asia Pacific Market Forecasts

Asia Pacific is expected to be the fastest-growing market for Glaucoma during the forecast period. The Asia-Pacific area is seeing an increase in glaucoma incidence as a result of changing lifestyles and longer life expectancies. The market is being driven by advancements in healthcare infrastructure and a growing public awareness of eye health. huge business opportunities are also generated by a huge population base.

Key Market Players

The Glaucoma Market is dominated by a few large companies, such as

·         Ziemer Ophthalmic SystemsTopcon

·         Lumenis

·         Novartis

·         Santen Pharmaceutical

·         New World Medical

·         Johnson & Johnson

·         Allergan

·         Ellex Medical Lasers

·         Abbott Laboratories

·         Others

Recent Developments:

·         September 2022, According to a joint statement from Santen Pharmaceutical Co., Ltd. and UBE Corporation, the U.S. Food and Drug Administration (FDA) approved OMLONTI® (omidenepag isopropyl ophthalmic solution) 0.002% eye drops today for the reduction of elevated intraocular pressure (IOP) in patients with primary open-angle glaucoma or ocular hypertension.

·         April 2023, The Janssen Pharmaceutical Companies of Johnson & Johnson is sponsoring five presentations at the Association for Research in Vision and Ophthalmology (ARVO) 2023 Annual Meeting, which will take place in New Orleans from April 23–27, 2023.

1.      Global Glaucoma Market Introduction and Market Overview

1.1.    Objectives of the Study

1.2.    Global Glaucoma Market Scope and Market Estimation

1.2.1. Global Glaucoma Overall Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2033)

1.2.2. Global Glaucoma Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2033

1.3.    Market Segmentation

1.3.1. Component of Global Glaucoma Market

1.3.2. Technology of Global Glaucoma Market

1.3.3. Distribution Channel of Global Glaucoma Market

1.3.4. Region of Global Glaucoma Market

2.      Executive Summary

2.1.    Global Glaucoma Market Industry Trends under COVID-19 Outbreak

2.1.1. Global COVID-19 Status Overview

2.1.2. Influence of COVID-19 Outbreak on Global Glaucoma Market Industry Development

2.2.    Market Dynamics

2.2.1. Drivers

2.2.2. Limitations

2.2.3. Opportunities

2.2.4. Impact Analysis of Drivers and Restraints

2.3.    Pricing Trends Analysis & Average Selling Prices (ASPs)

2.4.    Key Mergers & Acquisitions, Expansions, JVs, Funding / VCs, etc.

2.5.    Porter’s Five Forces Analysis

2.5.1. Bargaining Power of Suppliers

2.5.2. Bargaining Power of Buyers

2.5.3. Threat of Substitutes

2.5.4. Threat of New Entrants

2.5.5. Competitive Rivalry

2.6.    Value Chain / Ecosystem Analysis

2.7.    Russia-Ukraine War Impacts Analysis

2.8.    Economic Downturn Analysis

2.9.      Market Investment Opportunity Analysis (Top Investment Pockets), By Segments & By Region

3.      Global Glaucoma Market Estimates & Historical Trend Analysis (2019 - 2022)

4.      Global Glaucoma Market Estimates & Forecast Trend Analysis, by DISEASE TYPE

4.1.    Global Glaucoma Market Revenue (US$ Mn) Estimates and Forecasts, by DISEASE TYPE, 2019 to 2033

4.1.1. Angle Closure Glaucoma

4.1.2. Open Angle Glaucoma

4.1.3. Other

5.      Global Glaucoma Market Estimates & Forecast Trend Analysis, by Drug Class

5.1.    Global Glaucoma Market Revenue (US$ Mn) Estimates and Forecasts, by Drug Class, 2019 to 2033

5.1.1. Beta Blockers

5.1.2. Prostaglandin Analog

5.1.3. Adrenergic Agonist

5.1.4. Carbonic Anhydrase Inhibitors

5.1.5. Others

6.      Global Glaucoma Market Estimates & Forecast Trend Analysis, by Distribution Channel

6.1.    Global Glaucoma Market Revenue (US$ Mn) Estimates and Forecasts, by Distribution Channel, 2019 to 2033

6.1.1. Hospital Pharmacy

6.1.2. Retail Pharmacy

6.1.3. Online Pharmacy

7.      Global Glaucoma Market Estimates & Forecast Trend Analysis, by Region

7.1.    Global Glaucoma Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2033

7.1.1. North America

7.1.2. Europe

7.1.3. Asia Pacific

7.1.4. Middle East & Africa

7.1.5. South America

8.      North America Glaucoma Market: Estimates & Forecast Trend Analysis

8.1.    North America Glaucoma Market Assessments & Key Findings

8.1.1. North America Glaucoma Market Introduction

8.1.2. North America Glaucoma Market Size Estimates and Forecast (US$ Million) (2019 – 2033)

8.1.2.1.   By DISEASE TYPE

8.1.2.2.   By Drug Class

8.1.2.3.   By Distribution Channel

8.1.2.4.   By Country

8.1.2.4.1.     The U.S.

8.1.2.4.2.     Canada

8.1.2.4.3.     Mexico

9.      Europe Glaucoma Market: Estimates & Forecast Trend Analysis

9.1.    Europe Glaucoma Market Assessments & Key Findings

9.1.1. Europe Glaucoma Market Introduction

9.1.2. Europe Glaucoma Market Size Estimates and Forecast (US$ Million) (2019 – 2033)

9.1.2.1.   By DISEASE TYPE

9.1.2.2.   By Drug Class

9.1.2.3.   By Distribution Channel

9.1.2.4.        By Country

9.1.2.4.1.     Germany

9.1.2.4.2.     U.K.

9.1.2.4.3.     France

9.1.2.4.4.     Italy

9.1.2.4.5.     Spain

9.1.2.4.6.     Russia

9.1.2.4.7.     Rest of Europe

10.  Asia Pacific Glaucoma Market: Estimates & Forecast Trend Analysis

10.1.  Asia Pacific Market Assessments & Key Findings

10.1.1.   Asia Pacific Glaucoma Market Introduction

10.1.2.   Asia Pacific Glaucoma Market Size Estimates and Forecast (US$ Million) (2019 – 2033)

10.1.2.1.    By DISEASE TYPE

10.1.2.2.    By Drug Class

10.1.2.3.    By Distribution Channel

10.1.2.4.    By Country

10.1.2.4.1. China

10.1.2.4.2. Japan

10.1.2.4.3. India

10.1.2.4.4. Australia

10.1.2.4.5. South Korea

10.1.2.4.6. ASEAN

10.1.2.4.7. Rest of Asia Pacific

11.  Middle East & Africa Glaucoma Market: Estimates & Forecast Trend Analysis

11.1.  Middle East & Africa Market Assessments & Key Findings

11.1.1.   Middle East & Africa Glaucoma Market Introduction

11.1.2.   Middle East & Africa Glaucoma Market Size Estimates and Forecast (US$ Million) (2019 – 2033)

11.1.2.1.    By DISEASE TYPE

11.1.2.2.    By Drug Class

11.1.2.3.    By Distribution Channel

11.1.2.4.    By Country

11.1.2.4.1. U.A.E.

11.1.2.4.2. Saudi Arabia

11.1.2.4.3. Egypt

11.1.2.4.4. South Africa

11.1.2.4.5. Rest of Middle East & Africa

12.  South America Glaucoma Market: Estimates & Forecast Trend Analysis

12.1.  South America Market Assessments & Key Findings

12.1.1.   South America Glaucoma Market Introduction

12.1.2.   South America Glaucoma Market Size Estimates and Forecast (US$ Million) (2019 – 2033)

12.1.2.1.    By DISEASE TYPE

12.1.2.2.    By Drug Class

12.1.2.3.    By Distribution Channel

12.1.2.4.    By Country

12.1.2.4.1. Brazil

12.1.2.4.2. Argentina

12.1.2.4.3. Colombia

12.1.2.4.4. Rest of South America

13.  Competition Landscape

13.1.  Global Glaucoma Market Competition Matrix & Benchmarking, by Leading Players / Innovators / Emerging Players / New Entrants

13.2.  Global Glaucoma Market Competition White Space Analysis, By Distribution Channel

13.3.  Global Glaucoma Market Competition Heat Map Analysis, By Distribution Channel

13.4.  Global Glaucoma Market Concentration & Company Market Shares (%) Analysis, 2022

14.  Company Profiles

14.1.                     Novartis

14.1.1.   Company Overview & Key Stats

14.1.2.   Financial Performance & KPIs

14.1.3.   Product Portfolio

14.1.4.   Business Strategy & Recent Developments

* Similar details would be provided for all the players mentioned below 

14.2.      Ziemer Ophthalmic SystemsTopcon

14.3.      Lumenis

14.4.      Santen Pharmaceutical

14.5.      New World Medical

14.6.      Johnson & Johnson

14.7.      Allergan

14.8.      Ellex Medical Lasers

14.9.      Abbott Laboratories

14.10.  Others

15.  Research Methodology

15.1.  External Transportations / Databases

15.2.  Internal Proprietary Database

15.3.  Primary Research

15.4.  Secondary Research

15.5.  Assumptions

15.6.  Limitations

15.7.  Report FAQs

16.  Research Findings & Conclusion